SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1817)10/17/2000 11:44:40 AM
From: scaram(o)uche  Respond to of 2001
 
>> The most benign explanation I can think of is that there are recognizably different patterns of scarring in the treatment vs. placebo MRI's and the reader (who was supposedly blinded) was consistently responding to those differences. <<

Yeah, that's my number one on the "good" list. Sort of like McKinley handing them to reader with a "Post-it" note in the upper right corner of each, reading either "A" or "P".

<sick g>



To: Biomaven who wrote (1817)10/17/2000 12:06:06 PM
From: D.Lu  Read Replies (1) | Respond to of 2001
 
What might happen with the multitude of lawsuits filed? Will they be consolidated into one settlement with each law firm collecting fees against Gliatech and its insurer? How would you rate the Company's chances of winning in court?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News